Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
boston blog main
boston top stories
8
×
national blog main
san francisco blog main
san francisco top stories
8
×
life sciences
national top stories
new york blog main
new york top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
deals
eli lilly
fda
ipo
drug prices
medicare
merck
novartis
pfizer
pricing
What
pharmaceutical
8
×
bio
roundup
cancer
american
based
best
companies
continue
crash
debate
drug
drugs
hasn’t
healthcare
industry
kind
latest
medicines
nash
new
people
policy
politicians
pressure
prices
scalps
trump’s
typically
u.s
alzheimer’s
appetite
away
bails
bets
black
brand
bread
bridgebio
bringing
Language
unset
Current search:
photo
×
" boston top stories "
×
" san francisco top stories "
×
pharmaceutical
×
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines